作者
Shunying Zhao,Yunxiao Shang,Yong Yin,Yingxue Zou,Yongsheng Xu,Li-Li Zhong,Hailin Zhang,Hua Zhang,Deyu Zhao,Tong Shen,Dongming Huang,Qiang Chen,Qiao-Zhi Yang,Yungang Yang,Xiaoyan Dong,Ling Li,Zhi‐Min Chen,Enmei Liu,Li Deng,Wenhui Jiang,Huanji Cheng,Guangmin Nong,Xiufang Wang,Yiping Chen,Rong Ding,Wei Zhou,Yuejie Zheng,Zhaobo Shen,Xiaoxia Lü,Chuangli Hao,Xiaoping Zhu,Jia Tan,Yan Wu,Gang Zou,Ki Rito,Jim Z. Wu,H M Liu,Xin Ni
摘要
Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the treatment of infants hospitalized with RSV infection.